US Patent 7351704 Indazole-carboxamide compounds as 5-HT

Patent 7351704 was granted and assigned to Theravance on April, 2008 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Theravance

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

73517040

Patent Inventor Names

Jyanwei Liu0

Paul R. Fatheree0

S. Derek Turner0

Roland Gendron0

Seok-Ki Choi0

Adam A. Goldblum0

Daniel D. Long0

Daniel Marquess0

Date of Patent

April 1, 2008

Patent Application Number

110601950

Date Filed

February 17, 2005

Patent Primary Examiner

‌

Margaret D. Seaman

Patent abstract

The invention provides novel indazole-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.